| - Industry | - Sector | - CEO | XSTO Exchange | SE0009607252 ISIN |
| Sweden Country | - Employees | - Last Dividend | - Last Split | - IPO Date |
Intervacc AB (publ) is at the forefront of veterinary vaccine development, focusing on delivering innovative solutions for animals in Sweden. Since its inception in 1983, the company has been dedicated to addressing the critical health challenges faced by livestock and companion animals through advanced vaccine technologies. Based in Hägersten, Sweden, Intervacc AB combines scientific research with market insights to develop vaccines that not only meet the health requirements of animals but also support the needs of farmers and pet owners. Besides its strong emphasis on research and development, the company extends its expertise to the marketing and distribution of a variety of veterinary products across the Nordic markets, encompassing a range of therapeutic areas for swine, horses, cattle, and sheep.
A pioneering vaccine developed for horses to combat equine strangles, a prevalent and infectious equine disease caused by the bacterium Streptococcus equi. Strangvac represents Intervacc AB’s commitment to advancing animal health through innovative biotechnological solutions.
Targets the pressing need for effective treatment against Streptococcus suis, a significant pathogen in swine that leads to a range of health issues in piglets. INV274 comprises antigens formulated to stimulate a robust immune response, thereby offering a preventive strategy against this disease.
A multi-component vaccine designed to protect dairy cows from multiple bacteria known to cause mastitis, a major concern for the dairy industry due to its impact on milk production and animal welfare. INV412 demonstrates Intervacc AB’s multidisciplinary approach to addressing complex diseases with profound economic impacts.
Alongside its product pipeline, Intervacc AB actively participates in the Nordic veterinary market, distributing a comprehensive array of pharmaceuticals and vaccines tailored for swine, horses, cattle, and sheep. This includes not only its own developed products but also a curated selection of veterinary solutions aimed at enhancing the overall health and productivity of livestock and companion animals.